Effect of Pneumatic Compression on Diaphragmatic Excursion in Hemodialysis Patients With Low Back Dysfunction
25. června 2026 aktualizováno: Hagar Atif Azab Othman, Cairo University
This study will be conducted to investigate any significant effect of pneumatic compression on diaphragmatic excursion in patients with low back dysfunction .
Přehled studie
Postavení
Zatím nenabíráme
Podmínky
Intervence / Léčba
Detailní popis
The prevalence of the musculoskeletal manifestations is high (76.4%) in the hemodialysis population .Pain is the most frequently reported symptom (44.9%). Seven studies (28%) reported back pain With a prevalence ranging from 14.29%-52%. In hemodialysis patients, Low back pain (LBP) can be attributed to sedentary lifestyle ،low physical performance, muscular weakness ،psychological factors, altered metabolic activity of the bones and joints, and rare causes such as tumor, spinal infection, and osteoporotic fractures.
Diaphragm is an important component of spine lumbar stability. In presence of low back pain ،there may be some alterations in this muscle like other muscles that are responsible for lumbar stabilization. Respiratory muscle training (RMT) has been proven to reduce pain intensity and improve respiratory muscle strength, physical function, balance, and consequently، the overall quality of life in several population groups.
Pneumatic compression device had a significant improvement in pulmonary functions and inspiratory muscle training. And pneumatic compression can be considered as an effective component for pulmonary rehabilitation in chronic obstructive pulmonary lung disease. patients. Up to investigated knowledge, No previous studies conducted to explore the effect of pneumatic compression versus Inspiratory muscle training on diaphragmatic function in patients with low back dysfunction .
Typ studie
Intervenční
Zápis (Odhadovaný)
50
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Hagar Azab, Master
- Telefonní číslo: 01018746727
- E-mail: hagaratif92@gmail.com
Studijní záloha kontaktů
- Jméno: Shimaa Ali, As professor
- Telefonní číslo: 01144242511
- E-mail: shymaaali@pt.cu.edu.eg
Studijní místa
-
-
-
Cairo, Egypt
- Hagar Atif Azab
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Ne
Popis
Inclusion Criteria:
- Patients have been on regular hemodialysis (three sessions a week) at least 6 months before the start of the study
- Patients 'Age between 40 and 60 years old
- Patients have not participated in any physical activity program at least 6 months before the start of the study
- Patients have chronic back pain > 3months
- Patients has non specific low back pain
- Body mass index (BMI) from 25 to 34.9 kg/m2.
- Patients are clinically and medically stable
Exclusion Criteria:
- Instability of patient's medical condition
- Patients with chest infection
- Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia,
- uncontrolled diabetes mellitus,
- Persistent systolic Blood Pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg
- Chronic lung disease which result in significant oxygen desaturation on exercise or pulmonary congestion
- Patients with lupus nephritis.
- Patients with Spondylodiscitis , Compression fracture, Spinal stenosis
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Pneumatic compression and inspiratory muscle Trainer group
Participants will receive resisted inspiratory exercises using pneumatic compression abdominal belt in addition to inspiratory muscle Trainer (3 sessions per week) for 12 weeks
|
Training program in the form of resisted inspiratory exercises using pneumatic compression device with abdominal sleeve on the top portion of the abdominal cavity beneath the xiphoid process.
The patient used a pursed-lip breathing method to exhale after inhaling slowly through the nose such that the stomach slid out against the abdominal sleeve of the device.
For 12 weeks, three times per week, the workout consisted of 10 sets with 4-5 breaths in each set and a rest period of 2-3 minutes.
the subject underwent training in the form of six sets of five deep breaths against the trainer, with 1-2 minutes of rest in between sessions.
Depending on their rate of perceived exertion, the patient determined the maximum training load at which they could effectively perform 10 breaths at maximum resistance.
A load equivalent to 30% of the patient's maximum inspiratory effort was used to begin the training .This unique load gradually increased as the inspiratory muscle got stronger.
At the conclusion of the three months, the training programmer had expanded by 5% to 10% per week, reaching 60% of the maximum inspiratory pressure.
|
|
Aktivní komparátor: Inspiratory muscle Trainer group
Participants will receive only training of the inspiratory muscles by (Threshold Inspiratory Muscle Trainer) (3 sessions per week) for 12 weeks
|
the subject underwent training in the form of six sets of five deep breaths against the trainer, with 1-2 minutes of rest in between sessions.
Depending on their rate of perceived exertion, the patient determined the maximum training load at which they could effectively perform 10 breaths at maximum resistance.
A load equivalent to 30% of the patient's maximum inspiratory effort was used to begin the training .This unique load gradually increased as the inspiratory muscle got stronger.
At the conclusion of the three months, the training programmer had expanded by 5% to 10% per week, reaching 60% of the maximum inspiratory pressure.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Diaphragmatic excursion
Časové okno: 12 weeks
|
Ultrasonography is an ideal tool and easy to be operated for evaluating diaphragm function.
Low thickening ratio at forced respiration is an early indicator of diaphragm dysfunction and is associated with adverse clinical outcomes in hemodialysis (HD) patients.
These findings suggest that routine screening for diaphragm dysfunction is in HD patients and intervention of diaphragm dysfunction is expected to be a novel strategy for improving the clinical outcomes in HD patients.
|
12 weeks
|
|
Pain intensity
Časové okno: 12 weeks
|
Visual analogue scale (VAS) will be used to assess pain intensity.
it is 10 centimeter line with 2 ends; 0 indicates no pain and 10 indicates the worst pain.
|
12 weeks
|
|
functional capacity
Časové okno: 12 weeks
|
The 6 Minute Walk Test (6MWT) is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
The patient will rest comfortably for 10 minutes prior to the test.
During this time blood pressure and heart rate are measured and potential contraindications assessed.
The 6MWT will be performed on the walking track in which is 30 meters on one lap and two small cones will be used to mark the walking track boundaries.
|
12 weeks
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Functional disability
Časové okno: 12 weeks
|
The Oswestry Disability Index (ODI) has become well-researched gold standard for assessing the severity of disability caused by back pain.
The ODI covers 1 item on pain and 9 items on activities of daily living (personal care, lifting, walking، sitting, standing, sleeping, sex life, social life, and traveling.
Each section contains 6 statements scored from 0 to 5, where 0 is no disability and 5 is the maximum.
Scores are calculated as a percentage: (Total Points ÷ Total Possible Points) × 100.
|
12 weeks
|
|
Health-related Quality of life
Časové okno: 12 weeks
|
The SF-12 Health Survey Questionnaire is used to evaluate the health-related quality of life (HR-QoL) before and after the interventions.
The SF-12 consists of 12 questions that examine eight different health domains in order to determine physical and mental health.
General Health (GH), Physical Functioning (PF), Role Physical RP), and Body Pain (BP) are the physical health domains.
Vitality) VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH) are mental health-related scales.
A score above 50 indicates better-than-average health, while a score below 50 indicates below-average perceived health.
|
12 weeks
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Sponzor
Vyšetřovatelé
- Ředitel studie: Hany Saeed, As Professor, Cairo University
- Studijní židle: Heba Abd Elghafar, As professor, Cairo University
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Odhadovaný)
1. července 2026
Primární dokončení (Odhadovaný)
1. listopadu 2026
Dokončení studie (Odhadovaný)
30. listopadu 2026
Termíny zápisu do studia
První předloženo
25. června 2026
První předloženo, které splnilo kritéria kontroly kvality
25. června 2026
První zveřejněno (Aktuální)
1. července 2026
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
1. července 2026
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
25. června 2026
Naposledy ověřeno
1. června 2026
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- P.T.REC/012/005447
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .